Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01604590 · ClinicalTrials.gov registry record
Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 13
- Enrollment target
NCT01604590 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 13 participants.
The verdict
NCT01604590 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This study is for subjects with a diagnosis of a brain tumor called glioblastoma that is being treated with bevacizumab. This study will use a new MRI technique to compare the images of blood vessels and tumor structure to the effectiveness of bevacizumab.
Interventions
- RADIATION Magnetic Resonance Imaging (MRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01604590
The ClinicalTrials.gov registry entry for NCT01604590 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT01604590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01604590 about?
NCT01604590 is a clinical study titled "Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme". This study is for subjects with a diagnosis of a brain tumor called glioblastoma that is being treated with bevacizumab. This study will use a new MRI technique to compare the images of blood vessels and tumor structure to the effectiveness of bevacizumab.
What is the current status of trial NCT01604590?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2012-07. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01604590?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (RADIATION).
Who is sponsoring clinical trial NCT01604590?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.